Back to HUM Overview
NYQ · Valuation Lab
HUM
Humana Inc.
Last$363.82
Market cap43.7B
EV/EBITDA9.6x
Intrinsic value
$1503.95
MoS +75.8% · Undervalued
Assuming 1.3% FCF margin and 26.2% Y1–5 growth.
Upside to price
EV (DCF)171.5B
Terminal share76%
Expected IV$2340.76
Probability weights
Projected free cash flows
Stage FCF path with present values · terminal 76% of EV
PV of stage FCFs41.6B
PV of terminal value129.9B
Enterprise value171.5B
Net cash / (debt)9.1B
Equity value180.6B
Intrinsic value / share$1503.95
| Year | Revenue | FCF | PV | DF |
|---|---|---|---|---|
| Y1 | 183.8B | 2.4B | 2.2B | 93.5% |
| Y2 | 232B | 3B | 2.6B | 87.3% |
| Y3 | 292.8B | 3.8B | 3.1B | 81.6% |
| Y4 | 369.5B | 4.8B | 3.7B | 76.3% |
| Y5 | 466.3B | 6.1B | 4.3B | 71.3% |
| Y6 | 527.4B | 6.9B | 4.6B | 66.6% |
| Y7 | 596.5B | 7.8B | 4.8B | 62.3% |
| Y8 | 674.7B | 8.8B | 5.1B | 58.2% |
| Y9 | 763B | 9.9B | 5.4B | 54.4% |
| Y10 | 863B | 11.2B | 5.7B | 50.8% |
| Terminal | — | — | 129.9B | — |
Educational DCF model only — not financial advice. Terminal value and assumptions dominate results; verify filings and run your own diligence.